China's Clover begins human trials of COVID-19 shot with GSK, Dynavax boosters
June 19, 2020 at 03:38 AM EDT
A potential coronavirus vaccine being developed by China's Clover Biopharmaceuticals using GlaxoSmithKline's vaccine booster is now in early-stage testing in humans, the companies said on Friday.
